ERBB2 and breast carcinoma: Using this antibody, we detected HER2–103 expression in several established breast cancer cell lines, including HER2 positive BT474, SK-BR-3, TNBC MDA-MB-468, MDA-MB-231, MDA-MB-453, BT549, and luminal T47D, MCF7 (Fig. 3g).